Marten-Tab 50 mg / 325 mg Oral Tablet
RxNorm 209826
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 209826 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: Marten-Tab 50 mg / 325 mg Oral Tablet.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
SBDPrescribable
Semantic Branded Drug (SBD):
Acetaminophen 325 mg / butalbital 50 mg Oral Tablet [Marten-Tab]
(Atom ID: 12355636)
SYPrescribable
Synonym (SY):
APAP 325 mg / butalbital 50 mg Oral Tablet [Marten-Tab]
(Atom ID: 3855637)
SYPrescribable
Synonym (SY):
Marten-Tab (APAP 325 mg / butalbital 50 mg) Oral Tablet
(Atom ID: 3609321)
PSNPrescribable